It was found that in batches 2127580 and 2132779 the level of the impurity N-nitroso fluoxetine exceeds the temporary limit acceptable to EMA, which means loss of the required quality of the medicine and a potential risk to human health. Potential effects: possible carcinogenic effects with long-term use, impaired treatment efficacy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Seronil 20 mg from batches 2127580 and 2132779. Check the batch number on the packaging; if you possess these batches, return the product to a pharmacy and consult your doctor or pharmacist...
The Chief Pharmaceutical Inspector withdrew Seronil 20 mg hard capsules batches 2127580 and 2132779 from the entire national market, prohibited their placing on the market, and granted the decision im...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related